Lindsay is a behavioral scientist and Principal at IQVIA, where she provides scientific and technical leadership in the use of technology to advance patient-centered clinical research, with a focus on electronic clinical outcomes assessments (eCOAs)
Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): A multicentre, randomised, double-blind, placebo-controlled phase 3 trial
Clinical And Experimental Pharmacology & Physiology
joe bernstein He told me he wasnt able to tell me everything that hes ever taken, because it would essentially take so long
Cognitive impairment, ranging from mild cognitive dysfunction to Parkinsons disease dementia (PDD), affects up to 80% of individuals in advanced stages (25)
Potential side effects might include minor soreness or bruising at the injection site 3